BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6959544)

  • 1. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of acute leukemias in children. 2].
    Jacquillat C; Weil M; Schaison G; Delobel J; Bussel A; Brunel-Kotschi R; Gemon MF; Loisel JP
    Med Klin; 1972 Aug; 67(32):1040-5. PubMed ID: 4506878
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
    Shapiro RS; Gerrard JM; Ramsay NK; Nesbit ME; Coccia PF; Stoddard SF; Plow EF; White JG; Krivit W
    Am J Pediatr Hematol Oncol; 1980; 2(3):207-12. PubMed ID: 6933865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
    Jacquillat C; Weil M; Bussel A; Loisel JP; Rouesse T; Larrieu MJ; Boiron M; Dreyfus B; Bernard J
    Recent Results Cancer Res; 1970; 33():263-78. PubMed ID: 5292720
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
    Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
    Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 9. L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms.
    Haskell CM
    Cancer Treat Rep; 1981; 65 Suppl 4():57-9. PubMed ID: 7049381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
    Pui CH; Jackson CW; Chesney C; Lyles SA; Bowman WP; Abromowitch M; Simone JV
    J Clin Oncol; 1983 Jun; 1(6):380-5. PubMed ID: 6583320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 13. A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia.
    Priest JR; Ramsay NK; Steinherz PG; Tubergen DG; Cairo MS; Sitarz AL; Bishop AJ; White L; Trigg ME; Levitt CJ; Cich JA; Coccia PF
    J Pediatr; 1982 Jun; 100(6):984-9. PubMed ID: 6953221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
    Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
    J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.
    Cairo MS; Lazarus K; Gilmore RL; Baehner RL
    J Pediatr; 1980 Nov; 97(5):829-33. PubMed ID: 6933231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 18. L-Asparaginase-induced coagulopathy during therapy of acute lymphocytic leukemia.
    Sills RH; Nelson DA; Stockman JA
    Med Pediatr Oncol; 1978; 4(4):311-3. PubMed ID: 281595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dural sinus thrombosis in children with acute lymphoblastic leukemia.
    Steinherz PG; Miller LP; Ghavimi F; Allen JC; Miller DR
    JAMA; 1981 Dec; 246(24):2837-9. PubMed ID: 6947095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
    Earl M
    Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.